Riverbridge Partners LLC Increases Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Riverbridge Partners LLC grew its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 19.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,824,458 shares of the company’s stock after purchasing an additional 958,418 shares during the quarter. Privia Health Group makes up about 1.6% of Riverbridge Partners LLC’s holdings, making the stock its 22nd largest position. Riverbridge Partners LLC owned 4.85% of Privia Health Group worth $113,868,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Millennium Management LLC raised its holdings in shares of Privia Health Group by 2,994.2% in the second quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock valued at $19,788,000 after buying an additional 1,101,730 shares during the last quarter. Eventide Asset Management LLC raised its stake in shares of Privia Health Group by 979.2% during the 3rd quarter. Eventide Asset Management LLC now owns 822,438 shares of the company’s stock worth $14,977,000 after buying an additional 746,231 shares in the last quarter. Icon Wealth Advisors LLC lifted its holdings in shares of Privia Health Group by 1,910.1% in the 3rd quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company’s stock valued at $5,479,000 after buying an additional 285,920 shares during the period. FMR LLC boosted its position in shares of Privia Health Group by 1.5% during the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after purchasing an additional 271,645 shares in the last quarter. Finally, BlackBarn Capital Partners LP increased its holdings in Privia Health Group by 100.0% in the second quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock valued at $6,952,000 after buying an additional 200,000 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on PRVA shares. Truist Financial lifted their price target on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Macquarie initiated coverage on Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 target price on the stock. Barclays increased their price objective on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. KeyCorp began coverage on shares of Privia Health Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price for the company. Finally, JPMorgan Chase & Co. raised their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Privia Health Group currently has an average rating of “Buy” and an average target price of $24.88.

Privia Health Group Trading Down 0.2 %

NASDAQ PRVA opened at $22.68 on Thursday. The company’s fifty day simple moving average is $21.02 and its 200-day simple moving average is $19.72. The stock has a market cap of $2.72 billion, a P/E ratio of 226.82, a PEG ratio of 3.07 and a beta of 0.85. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $23.49.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.